BostonGene Corporation announced a strategic collaboration with Unilever. The partnership will draw on BostonGene?s proprietary analytical capabilities to support Unilever?s broader scientific exploration and long-term innovation ambitions. The collaboration combines BostonGene?s omnimodal data integration and advanced AI capabilities with Unilever?s scientific expertise.

The companies will explore scientific factors that shape individual differences in biology to identify insights that can support future product development. The collaboration extends BostonGene's foundation model beyond oncology into new areas of human biology, using advanced AI to accelerate discoveries that will help shape the future of consumer-focused science and innovation.